Belle Capital Fund

BELLE Capital is a U.S.-based early-stage venture and angel investment firm rather than a drug-development operating company. The firm invests across several sectors, including life sciences, medical devices, digital health, health IT, and broader technology markets, with a stated focus on capital-efficient companies in underserved geographies. In healthcare, BELLE Capital appears to back startups in areas such as ophthalmology, medical devices, and digital health rather than developing its own therapeutic pipeline. The organization is known for supporting early-stage companies and has been described as a women-led investment platform. For biotech analysts, BELLE Capital is best understood as an investor with exposure to healthcare and life sciences, not as a biotech, pharma, CRO, or CDMO company.